Target intelligence / Profile preview

Tendon regeneration

Molecular classification
Other (Biological Process)
01

Overview

Tendon regeneration is a complex physiological process aimed at restoring the structural integrity and mechanical function of tendons following acute rupture or chronic tendinopathy. Unlike a single molecular target such as a receptor or enzyme, it involves a coordinated cascade of events including inflammation, cell proliferation, and extracellular matrix (ECM) remodeling. Key molecular drivers of this process include growth factors such as Transforming Growth Factor-beta (TGF-beta) and Growth Differentiation Factor 5 (GDF-5), along with tenogenic transcription factors like Scleraxis (SCX) and Mohawk (MKX). Therapeutic interventions in this field often target these pathways to promote the synthesis of Type I collagen and the maturation of tenocytes, seeking to avoid the formation of dysfunctional scar tissue. Currently, tendon regeneration is viewed as a clinical objective in regenerative medicine, utilizing biologics like platelet-rich plasma, stem cells, and recombinant growth factors to enhance the body's natural healing capacity. Because it encompasses an entire biological pathway rather than an individual protein, it is categorized as a therapeutic goal rather than a discrete drug target. (Sources: PMID: 25681105, PMID: 28932698, StatPearls)

Other names
Tendon healingTendon repairTenogenesisTendon tissue engineering
02

Mechanism of action

Induction of tenogenic transcription factors, stimulation of tenocyte proliferation, and modulation of collagen fiber alignment and extracellular matrix synthesis.

03

Biological functions

Cell proliferationCell differentiationExtracellular matrix organizationTissue remodelingWound healingTenogenesis
04

Disease associations

TendinopathyTendon ruptureAchilles tendon injuryRotator cuff tearLigament injury
05

Safety considerations

Ectopic bone formation (heterotopic ossification)Fibrosis and scar tissue formationPeritendinous adhesionsImmunogenic response to scaffoldsReduced mechanical strength during remodeling
06

Interacting drugs

Growth differentiation factor 5 (GDF-5)

4 more in the full profile.

07

Biomarkers

Scleraxis (SCX)Tenomodulin (TNMD)Mohawk homeobox (MKX)Type I Collagen (COL1A1)Type III Collagen (COL3A1)Tenascin-C

Beyond the preview

Go deeper on Tendon regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tendon regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call